Section Arrow
MYGN.NASDAQ
- Myriad Genetics
Quotes are at least 15-min delayed:2025/07/02 23:01 EDT
Last
 5.63
+0.1 (+1.81%)
Day High 
5.715 
Prev. Close
5.53 
1-M High
5.7401 
Volume 
1.39M 
Bid
5.3
Ask
5.75
Day Low
5.465 
Open
5.55 
1-M Low
4.17 
Market Cap 
509.74M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 5.14 
20-SMA 5.12 
50-SMA 5.31 
52-W High 29.3 
52-W Low 3.8119 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.12/0.13
Enterprise Value
637.24M
Balance Sheet
Book Value Per Share
7.65
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
837.60M
Operating Revenue Per Share
7.97
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.23+0.15+2.95%879PE
BIAFbioAffinity Technologies0.29+0.0265+10.06%-- 
DHRDanaher Corp202.5+1.4+0.70%38.97PE
OPKOPKO Health1.34+0.01+0.75%-- 
TMOThermo Fisher Scientific427.76+6.29+1.49%24.72PE
Quotes are at least 15-min delayed:2025/07/02 23:01 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.